• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Therabody Pours $10M into Scientific Research, Formalizes Advisory Board

by Jasmine Pennic 03/15/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Therabody, an innovator in wellness technology is pledging over $10M to fund scientific and clinical research studies across beauty, wellness, and athletic performance.

– The investment reflects their commitment to scientific validation in a rapidly evolving healthcare landscape.  Therabody will also launch its first grant program to support researchers globally who are merging wellness and technology in their work.

Therabody & ACSM Partnership

A key element of this initiative is a strategic partnership with the American College of Sports Medicine (ACSM), the world’s preeminent organization for sports medicine research.  The strategic collaboration will involve:

– Therabody’s Sponsorship and Exhibition at the 2024 ACSM Annual Meeting: Therabody will showcase their cutting-edge recovery therapies, demonstrating their commitment to staying at the forefront of athletic performance recovery solutions.

– Research Grant Program: Therabody and ACSM will co-fund research grants, fostering further scientific exploration in the field.

– Supporting Women’s Health & Fitness: Therabody aligns with ACSM’s Strategic Health Initiative for Women, Sport, and Physical Activity, promoting women’s health and fitness initiatives.

Therabody Scientific Advisory Board Established

Therabody also announced the formation of their Scientific Advisory Board, comprised of renowned experts across various health and wellness disciplines:

– Dr. Pamela Peeke: A leader in integrative medicine and women’s health, Dr. Peeke brings expertise in women’s specific health needs.

– Dr. Daniel Giordano: Specializing in performance health and longevity, Dr. Giordano focuses on diverse populations and rehabilitation.

– Dr. Robin Thorpe: A global authority in recovery science, Dr. Thorpe has extensive experience working with elite athletes in various sports.

– Dr. Neera Nathan: A Harvard-trained dermatologist, Dr. Nathan contributes expertise in dermatology and aesthetics.

These esteemed professionals will collaborate with Therabody’s scientific team to broaden research networks, advise on research strategies, and co-develop innovative wellness solutions aligned with their areas of specialization.

“I am thrilled to welcome this caliber of scientific leadership to Therabody. Our Scientific Advisory Board, along with our significant investment in scientific research and partnerships, will ensure we remain at the forefront of our industry and dedicated to developing the most effective, scientifically validated products available today and in the future,” said Monty Sharma, President and CEO of Therabody.

Since its inception, Therabody has emphasized a science-driven approach.  The company has completed 21 scientific studies to date, with 26 currently underway. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |